USPH
U S Physical Therapy Inc /nv Health Care Services-Health Services Russell 3000
$85.83Close
$1.5BMarket cap
$58.22 – $88.7352-week range
Nov 4, 2026Next report · after the close
Highlights
Strengths
- Near its high 3% below its 52-week high
Cautions
- Trend not confirmed 6 of 8 conditions · 150-day under the 200-day, RS under 70
- Earnings shrinking EPS −19% year on year
- Results soon Nov 4, 2026, in 3 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
3%
1wk
down 3.0%
price change
1mo
up 0.1%
price change
12-month return
up 2%
market up 11% ·
its own down 11%
F-score
6 / 9
Mixed
Altman Z″
2.26
Moderate risk
P/E
37.8×
price / earnings
PEG
1.51
P/E / EPS growth
P/B
3.1×
price / book
Earnings yield
up 5.4%
EBIT / enterprise value
Cheaper than
60%
of the market · cheap
Revenue growth
up 16%
year on year
EPS growth
down 19%
latest quarter · +30 pts
Sales growth
up 8%
latest quarter · +1 pts
ROE
up 8%
return on equity
Free cash margin
up 8%
$61.0M FCF
D/E
0.32
long-term debt / equity
Net debt / EBITDA
1.1×
Interest cover
—EBIT / interest
Piotroski tests
- short-term liquidity weakened
- issued more shares
- assets working less efficiently
- profitable on its assets
- generating cash from operations
- profitability improving
- profits backed by cash
- reduced long-term debt
- gross margin widened
Trade setup
ATR%
3.1%
$2.67 a day · 2×ATR $80.48
RS
61 / 99
vs the universe
Trend
6 / 8
150-day under the 200-day, RS under 70
Relative volume
0.9×
vs 50-day average
Up/down volume
1.16
50 sessions
Implied move
—
no option chain · report Nov 4, 2026
Trend template · 6 of 8
- 150-day average above the 200-day: fails
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- Interest covered
- No material dilution
- Profits tracking cash
- Margins and revenue not shrinking
Last reported
Aug 6, 2026
Results reaction
Aug 6, 2026+3% vs market2 sessions after results
Financials
- Gross 19%
- Net 5%
- Free cash 8%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $423.0M | $495.0M | $553.1M | $604.8M | $671.3M | $781.0M |
| Gross margin | 22% | 24% | 20% | 20% | 18% | 19% |
| Operating income | $52.4M | $70.6M | $56.8M | $50.5M | $63.0M | $86.7M |
| Net income | $35.2M | $40.8M | $32.2M | $28.2M | $31.4M | $39.6M |
| Net margin | 8% | 8% | 6% | 5% | 5% | 5% |
| Earnings per share | $2.74 | $3.17 | $2.48 | $1.99 | $2.09 | $2.61 |
| Free cash flow | $92.4M | $68.2M | $50.3M | $72.7M | $65.8M | $61.0M |
| Free cash margin | 22% | 14% | 9% | 12% | 10% | 8% |
| Cash | $32.9M | $28.6M | $31.6M | $152.8M | $41.4M | $35.6M |
| Long-term debt | $16.6M | $117.6M | $175.8M | $139.0M | $142.5M | $152.6M |
| Shareholders' equity | $276.2M | $295.6M | $315.8M | $476.2M | $488.9M | $476.4M |
| Shares outstanding | 15.07m | 15.13m | 15.22m | 17.20m | 17.31m | 17.42m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 7, 2026 | Quarterly ↗ | Jun 30, 2026 | 38d |
| May 8, 2026 | Quarterly ↗ | Mar 31, 2026 | 38d |
| Feb 27, 2026 | Annual ↗ | Dec 31, 2025 | 58d |
| Nov 7, 2025 | Quarterly ↗ | Sep 30, 2025 | 38d |
| Aug 8, 2025 | Quarterly ↗ | Jun 30, 2025 | 39d |
| May 9, 2025 | Quarterly ↗ | Mar 31, 2025 | 39d |
| Mar 3, 2025 | Annual ↗ | Dec 31, 2024 | 62d |
| Nov 8, 2024 | Quarterly ↗ | Sep 30, 2024 | 39d |
| Aug 14, 2024 | Quarterly ↗ | Jun 30, 2024 | 45d |
| May 8, 2024 | Quarterly ↗ | Mar 31, 2024 | 38d |
| Feb 29, 2024 | Annual ↗ | Dec 31, 2023 | 60d |
| Nov 8, 2023 | Quarterly ↗ | Sep 30, 2023 | 39d |
Current reports
| Filed | Disclosed |
|---|---|
| Sep 28, 2026 | Material agreement · New obligation ↗ |
| Sep 21, 2026 | Director or officer change ↗ |
| Aug 14, 2026 | Material agreement · Director or officer change · Other events ↗ |
| Aug 12, 2026 | Regulation FD ↗ |
| Aug 10, 2026 | Regulation FD ↗ |
| Aug 6, 2026 | Results · Other events ↗ |
| Jul 6, 2026 | Other events ↗ |
| May 19, 2026 | Shareholder vote ↗ |
| May 11, 2026 | Regulation FD ↗ |
| May 6, 2026 | Results · Other events ↗ |
| Apr 15, 2026 | Material agreement · New obligation ↗ |
| Mar 13, 2026 | Director or officer change ↗ |